...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Protective Effects of Huang-Lian-Jie-Du-Tang against Polymicrobial Sepsis Induced by Cecal Ligation and Puncture in Rats
【24h】

Protective Effects of Huang-Lian-Jie-Du-Tang against Polymicrobial Sepsis Induced by Cecal Ligation and Puncture in Rats

机译:黄连解毒汤对大鼠盲肠结扎穿刺致细菌性败血症的保护作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Huang-Lian-Jie-Du-Tang (HLJDT) is a traditional formula that has long been used for treatment of inflammatory diseases in Traditional Chinese Medicine. In this study, we examined its protective effect against sepsis in an experimental septic model induced by cecal ligation and puncture (CLP) in rats. The results demonstrated that prophylactic administration of HLJDT protected rats from CLP-induced lethality and ameliorated CLP-induced liver and lung injury. HLJDT treatment suppressed the production of proinflammatory cytokines, including TNF-a, IL-1, IL-6, and IL-17A, indicating HLJDT could limit excessive inflammatory responses in septic condition. In addition, HLJDT facilitated bacterial clearance by increasing phagocytic activities of peritoneal macrophages. Furthermore, HLJDT treatment reversed CLP-induced suppression of IFN-y expression and blocked CLP-induced increase in IL-4 expression in spleens of rats at 24 h after CLP, indicating that HLJDT could reverse the shift from Thl to Th2 response and promote Thl/Th2 balance toward Thl predominance in septic rats. Moreover, HLJDT also inhibited the expression of IL-17A and ROR-yt in spleens of septic rats, indicating HLJDT is able to inhibit Thl7 activation in septic condition. In conclusion, the present study demonstrated the protective effects of HLJDT against sepsis and highlighted the potential of HLJDT as a medication for septic patients.
机译:黄连洁堂汤(HLJDT)是一种传统配方,长期以来一直用于治疗中药中的炎症性疾病。在这项研究中,我们在大鼠盲肠结扎穿刺(CLP)诱导的实验性脓毒症模型中检查了其对败血症的保护作用。结果表明,预防性给予HLJDT可保护大鼠免受CLP致死性的影响,并减轻CLP致肝肺损伤。 HLJDT处理抑制了促炎细胞因子的产生,包括TNF-α,IL-1,IL-6和IL-17A,这表明HLJDT可以限制败血症条件下过度的炎症反应。此外,HLJDT通过增加腹膜巨噬细胞的吞噬活性来促进细菌清除。此外,HLJDT处理可逆转CLP诱导的大鼠CLP后24 h脾脏中CLP诱导的IFN-γ表达抑制,并阻止CLP诱导的脾脏IL-4表达增加,这表明HLJDT可以逆转从Th1应答向Th2应答的转变并促进Th1应答/ Th2平衡在败血症大鼠中占Th1优势。此外,HLJDT还抑制败血症大鼠脾脏中IL-17A和ROR-yt的表达,这表明HLJDT能够抑制败血症条件下Thl7的活化。总之,本研究证明了HLJDT对败血症的保护作用,并强调了HLJDT作为败血病患者的药物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号